Global Artificial Blood Substitute Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Artificial Blood Substitute Market
Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.

The global Artificial Blood Substitute market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.

Artificial blood substitutes are used as oxygen therapy agents for emergency resuscitation and disease treatment. They have very important practical significance in developing countries and field hospitals that lack blood and urgently need blood transfusion, lack refrigeration equipment, and even on the battlefield. At the same time they do have great potential in reducing the spread of infectious diseases and providing new options for religious people who refuse blood transfusions.

Despite the huge application prospects, these artificial blood products all face some common problems. In addition to the safety and efficacy to be verified by clinical trials, the current production scale still needs to be greatly increased, and the production cost needs to be greatly reduced to meet the future demand for artificial blood .

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Artificial Blood Substitute market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Artificial Blood Substitute market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Artificial Blood Substitute market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Artificial Blood Substitute market.

Impact of Covid-19 Outbreak

This section of the report has explored the overall status of the Covid scenario and has offered valuable insights into the changes in supply chain disruption, fluctuations in demand, etc. The analysts have also focused on the key measures that the companies are opting to withstand the harsh scenario.

Segmental Analysis

The report has been segmented into product and application segments. The researchers have documented all the products present today in the Artificial Blood Substitute market. They have also shed light on the new product innovations and launches by the key players. In the segmental analysis, the analysts have provided revenue forecast figures based on type and application for the period 2017-2028. They have also discussed about the growth rate and potential of each segment for the period 2017-2028.

Artificial Blood Substitute Breakdown Data by Type

Perfluorocarbon-based Oxygen Carrier (PFBOC)

Hemoglobin-based Oxygen Carrier (HBOC)

Artificial Blood Substitute Breakdown Data by Application

Military

Civil

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Competitive Landscape

This segment focuses on the key players operating in the industry. It underlines all the current and future activities by the prominent manufacturers. By understanding various initiatives being taken up by different players, readers will gain the ability to settle on correct business choices. The authors of the report have provided accurate revenue figures of the companies for the period 2017-2022. The clients are sure to gain the upper hand once they get hold of this report. Key players studied in the research report include:

Aurum Biosciences Ltd.

HEMARINA SA

HbO2 Therapeutics

KaloCyte Inc.

SpheriTech Ltd.

NuvOx Pharma

TABLE OF CONTENT

1 Report Business Overview
1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Artificial Blood Substitute Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)

1.2.3 Hemoglobin-based Oxygen Carrier (HBOC)

1.3 Market by Application

1.3.1 Global Artificial Blood Substitute Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Military

1.3.3 Civil

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Artificial Blood Substitute Market Perspective (2017-2028)

2.2 Artificial Blood Substitute Growth Trends by Region

2.2.1 Artificial Blood Substitute Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Artificial Blood Substitute Historic Market Size by Region (2017-2022)

2.2.3 Artificial Blood Substitute Forecasted Market Size by Region (2023-2028)

2.3 Artificial Blood Substitute Market Dynamics

2.3.1 Artificial Blood Substitute Industry Trends

2.3.2 Artificial Blood Substitute Market Drivers

2.3.3 Artificial Blood Substitute Market Challenges

2.3.4 Artificial Blood Substitute Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Artificial Blood Substitute Players by Revenue

3.1.1 Global Top Artificial Blood Substitute Players by Revenue (2017-2022)

3.1.2 Global Artificial Blood Substitute Revenue Market Share by Players (2017-2022)

3.2 Global Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Artificial Blood Substitute Revenue

3.4 Global Artificial Blood Substitute Market Concentration Ratio

3.4.1 Global Artificial Blood Substitute Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Artificial Blood Substitute Revenue in 2021

3.5 Artificial Blood Substitute Key Players Head office and Area Served

3.6 Key Players Artificial Blood Substitute Product Solution and Service

3.7 Date of Enter into Artificial Blood Substitute Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Artificial Blood Substitute Breakdown Data by Type

4.1 Global Artificial Blood Substitute Historic Market Size by Type (2017-2022)

4.2 Global Artificial Blood Substitute Forecasted Market Size by Type (2023-2028)

5 Artificial Blood Substitute Breakdown Data by Application

5.1 Global Artificial Blood Substitute Historic Market Size by Application (2017-2022)

5.2 Global Artificial Blood Substitute Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Artificial Blood Substitute Market Size (2017-2028)

6.2 North America Artificial Blood Substitute Market Size by Type

6.2.1 North America Artificial Blood Substitute Market Size by Type (2017-2022)

6.2.2 North America Artificial Blood Substitute Market Size by Type (2023-2028)

6.2.3 North America Artificial Blood Substitute Market Share by Type (2017-2028)

6.3 North America Artificial Blood Substitute Market Size by Application

6.3.1 North America Artificial Blood Substitute Market Size by Application (2017-2022)

6.3.2 North America Artificial Blood Substitute Market Size by Application (2023-2028)

6.3.3 North America Artificial Blood Substitute Market Share by Application (2017-2028)

6.4 North America Artificial Blood Substitute Market Size by Country

6.4.1 North America Artificial Blood Substitute Market Size by Country (2017-2022)

6.4.2 North America Artificial Blood Substitute Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Artificial Blood Substitute Market Size (2017-2028)

7.2 Europe Artificial Blood Substitute Market Size by Type

7.2.1 Europe Artificial Blood Substitute Market Size by Type (2017-2022)

7.2.2 Europe Artificial Blood Substitute Market Size by Type (2023-2028)

7.2.3 Europe Artificial Blood Substitute Market Share by Type (2017-2028)

7.3 Europe Artificial Blood Substitute Market Size by Application

7.3.1 Europe Artificial Blood Substitute Market Size by Application (2017-2022)

7.3.2 Europe Artificial Blood Substitute Market Size by Application (2023-2028)

7.3.3 Europe Artificial Blood Substitute Market Share by Application (2017-2028)

7.4 Europe Artificial Blood Substitute Market Size by Country

7.4.1 Europe Artificial Blood Substitute Market Size by Country (2017-2022)

7.4.2 Europe Artificial Blood Substitute Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Artificial Blood Substitute Market Size (2017-2028)

8.2 Asia-Pacific Artificial Blood Substitute Market Size by Type

8.2.1 Asia-Pacific Artificial Blood Substitute Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Artificial Blood Substitute Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Artificial Blood Substitute Market Share by Type (2017-2028)

8.3 Asia-Pacific Artificial Blood Substitute Market Size by Application

8.3.1 Asia-Pacific Artificial Blood Substitute Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Artificial Blood Substitute Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Artificial Blood Substitute Market Share by Application (2017-2028)

8.4 Asia-Pacific Artificial Blood Substitute Market Size by Region

8.4.1 Asia-Pacific Artificial Blood Substitute Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Artificial Blood Substitute Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Artificial Blood Substitute Market Size (2017-2028)

9.2 Latin America Artificial Blood Substitute Market Size by Type

9.2.1 Latin America Artificial Blood Substitute Market Size by Type (2017-2022)

9.2.2 Latin America Artificial Blood Substitute Market Size by Type (2023-2028)

9.2.3 Latin America Artificial Blood Substitute Market Share by Type (2017-2028)

9.3 Latin America Artificial Blood Substitute Market Size by Application

9.3.1 Latin America Artificial Blood Substitute Market Size by Application (2017-2022)

9.3.2 Latin America Artificial Blood Substitute Market Size by Application (2023-2028)

9.3.3 Latin America Artificial Blood Substitute Market Share by Application (2017-2028)

9.4 Latin America Artificial Blood Substitute Market Size by Country

9.4.1 Latin America Artificial Blood Substitute Market Size by Country (2017-2022)

9.4.2 Latin America Artificial Blood Substitute Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Artificial Blood Substitute Market Size (2017-2028)

10.2 Middle East & Africa Artificial Blood Substitute Market Size by Type

10.2.1 Middle East & Africa Artificial Blood Substitute Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Artificial Blood Substitute Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Artificial Blood Substitute Market Share by Type (2017-2028)

10.3 Middle East & Africa Artificial Blood Substitute Market Size by Application

10.3.1 Middle East & Africa Artificial Blood Substitute Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Artificial Blood Substitute Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Artificial Blood Substitute Market Share by Application (2017-2028)

10.4 Middle East & Africa Artificial Blood Substitute Market Size by Country

10.4.1 Middle East & Africa Artificial Blood Substitute Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Artificial Blood Substitute Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Aurum Biosciences Ltd.

11.1.1 Aurum Biosciences Ltd. Company Details

11.1.2 Aurum Biosciences Ltd. Business Overview

11.1.3 Aurum Biosciences Ltd. Artificial Blood Substitute Introduction

11.1.4 Aurum Biosciences Ltd. Revenue in Artificial Blood Substitute Business (2017-2022)

11.1.5 Aurum Biosciences Ltd. Recent Developments

11.2 HEMARINA SA

11.2.1 HEMARINA SA Company Details

11.2.2 HEMARINA SA Business Overview

11.2.3 HEMARINA SA Artificial Blood Substitute Introduction

11.2.4 HEMARINA SA Revenue in Artificial Blood Substitute Business (2017-2022)

11.2.5 HEMARINA SA Recent Developments

11.3 HbO2 Therapeutics

11.3.1 HbO2 Therapeutics Company Details

11.3.2 HbO2 Therapeutics Business Overview

11.3.3 HbO2 Therapeutics Artificial Blood Substitute Introduction

11.3.4 HbO2 Therapeutics Revenue in Artificial Blood Substitute Business (2017-2022)

11.3.5 HbO2 Therapeutics Recent Developments

11.4 KaloCyte Inc.

11.4.1 KaloCyte Inc. Company Details

11.4.2 KaloCyte Inc. Business Overview

11.4.3 KaloCyte Inc. Artificial Blood Substitute Introduction

11.4.4 KaloCyte Inc. Revenue in Artificial Blood Substitute Business (2017-2022)

11.4.5 KaloCyte Inc. Recent Developments

11.5 SpheriTech Ltd.

11.5.1 SpheriTech Ltd. Company Details

11.5.2 SpheriTech Ltd. Business Overview

11.5.3 SpheriTech Ltd. Artificial Blood Substitute Introduction

11.5.4 SpheriTech Ltd. Revenue in Artificial Blood Substitute Business (2017-2022)

11.5.5 SpheriTech Ltd. Recent Developments

11.6 NuvOx Pharma

11.6.1 NuvOx Pharma Company Details

11.6.2 NuvOx Pharma Business Overview

11.6.3 NuvOx Pharma Artificial Blood Substitute Introduction

11.6.4 NuvOx Pharma Revenue in Artificial Blood Substitute Business (2017-2022)

11.6.5 NuvOx Pharma Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

Choose License Type

Checkout Inquiry Sample